US Clinical Chemistry & Immunodiagnostic Market Opportunities Investigated in New VPG Report Available at MarketPublishers.com Business Wire LONDON -- February 22, 2013 In the years ahead, the clinical chemistry and immunodiagnostics markets will see a remarkable metamorphosis worldwide, with the US being no exception. This transformation is likely to be brought about by the convergence of tighter regulations; advancements in diagnostic technologies, system engineering, automation and IT; as well as intense competition. The routine chemistry segment, for example, will be reminiscent of commodity markets, where market positioning and cost per test are of more importance than the technology itself. Some of the top US market participants include, among others, Abbott Laboratories, Roche, Beckman Siemens, Biomedical Diagnostics, BioMerieux, Bio-Rad, Sysmex, Dako, Eiken, Fujirebio, Instrumentation Laboratory, Kyowa Medex, Matritech, Ortho-Clinical Diagnostics. New report “Competing in the US Clinical Chemistry and Immunodiagnostic Markets” elaborated by Venture Planning Group (VPG) offers a comprehensive guide to the US clinical chemistry and immunodiagnostic laboratory practice during the next five years. Report Features: *insight into key economic, regulatory, demographic, social and technological trends with huge market impact in future; *volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays; *volume forecasts for specimens; *reagent and instrument sales forecasts; *review of current instrumentation technologies, with a feature comparison of 50 analyzers; *sales and market shares of top reagent and instrument suppliers; *analysis of existent and emerging technologies with their potential market applications; *product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables; *profiles of 25 current and emerging suppliers; *review of market penetration strategies, entry barriers and risks. Report Details: Title: Competing in the US Clinical Chemistry and Immunodiagnostic Markets Published: February, 2013 Pages: 600 Price: US$ 11,500.00 http://marketpublishers.com/report/diagnostics-diseases/in_vitro_diagnostics/competing-in-us-clinical-chemistry-n-immunodiagnostic-markets.html More US Diagnostics & Diseases Market Reports by VPG Include: *Competing in the US Infectious Disease Testing Market *Competing in the US Hematology and Flow Cytometry Markets *Competing in the US Molecular Diagnostics Market *Competing in the US Coagulation Market *Competing in the US Clinical Chemistry and Immunodiagnostic Markets *Competing in the US Cancer Diagnostics Market More new reports by VPG can be found at http://marketpublishers.com/members/vpg/info.html Contact: The Market Publishers, Ltd. Tanya Rezler Tel: +44 208 144 6009 Fax: +44 207 900 3970 firstname.lastname@example.org MarketPublishers.com
US Clinical Chemistry & Immunodiagnostic Market Opportunities Investigated in New VPG Report Available at MarketPublishers.com
Press spacebar to pause and continue. Press esc to stop.